Scholar Rock Holding Co. (NASDAQ:SRRK) Shares Sold by Fisher Asset Management LLC

Fisher Asset Management LLC lessened its holdings in shares of Scholar Rock Holding Co. (NASDAQ:SRRK) by 24.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 554,737 shares of the company’s stock after selling 179,282 shares during the quarter. Fisher Asset Management LLC owned 0.59% of Scholar Rock worth $23,976,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Wellington Management Group LLP grew its stake in Scholar Rock by 16.2% during the 3rd quarter. Wellington Management Group LLP now owns 199,777 shares of the company’s stock valued at $1,600,000 after purchasing an additional 27,801 shares in the last quarter. Charles Schwab Investment Management Inc. grew its stake in Scholar Rock by 9.1% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 502,793 shares of the company’s stock valued at $4,027,000 after purchasing an additional 42,139 shares in the last quarter. Barclays PLC grew its stake in Scholar Rock by 103.4% during the 3rd quarter. Barclays PLC now owns 165,449 shares of the company’s stock valued at $1,324,000 after purchasing an additional 84,118 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Scholar Rock by 7.1% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 94,795 shares of the company’s stock valued at $759,000 after purchasing an additional 6,269 shares in the last quarter. Finally, Geode Capital Management LLC grew its position in shares of Scholar Rock by 8.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,543,025 shares of the company’s stock worth $12,361,000 after acquiring an additional 120,489 shares in the last quarter. Institutional investors and hedge funds own 91.08% of the company’s stock.

Scholar Rock Trading Down 6.7 %

NASDAQ:SRRK opened at $36.23 on Tuesday. Scholar Rock Holding Co. has a 12-month low of $6.76 and a 12-month high of $46.98. The firm has a market capitalization of $3.39 billion, a P/E ratio of -15.42 and a beta of 0.50. The company has a debt-to-equity ratio of 0.63, a current ratio of 3.88 and a quick ratio of 3.88. The business has a 50 day simple moving average of $41.22 and a 200 day simple moving average of $29.64.

Analyst Ratings Changes

Several brokerages have recently commented on SRRK. Truist Financial lifted their target price on Scholar Rock from $36.00 to $45.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. Wedbush reiterated an “outperform” rating and issued a $47.00 target price on shares of Scholar Rock in a research report on Wednesday, January 29th. Finally, HC Wainwright lifted their target price on Scholar Rock from $40.00 to $50.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Six equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Scholar Rock presently has a consensus rating of “Buy” and an average price target of $40.43.

Insider Activity at Scholar Rock

In other Scholar Rock news, insider Mo Qatanani sold 68,510 shares of Scholar Rock stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $37.40, for a total transaction of $2,562,274.00. Following the sale, the insider now owns 111,084 shares of the company’s stock, valued at $4,154,541.60. The trade was a 38.15 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jing L. Marantz sold 5,655 shares of Scholar Rock stock in a transaction on Thursday, January 16th. The shares were sold at an average price of $44.20, for a total value of $249,951.00. Following the sale, the insider now directly owns 67,200 shares in the company, valued at $2,970,240. The trade was a 7.76 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 149,974 shares of company stock worth $5,927,710 in the last 90 days. 19.20% of the stock is currently owned by company insiders.

Scholar Rock Profile

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.